You are here

Home » List of Registration Dates » Companies registered on March 15, 2026

Hong Kong Companies Incorporated on March 15, 2026 and Daily Business News Overview

View the complete list of Hong Kong companies incorporated on March 15, 2026. This page also features daily updates on industry news, policies, and corporate intelligence to help you efficiently track market trends.

Chinese Name English Name
Reach Technologies Limited
恆鉑鑫科技有限公司 Hapoxin Technology Co., Limited
香港眾穩供應鏈管理有限公司 Hong Kong Zhong Wen Supply Chain Management Limited
香港融信泇合投資有限公司 Hong Kong Rongxin Jihe Investment Co., Limited
鼎凡貿易有限公司 DING FAAN TRADING LIMITED
MLH99 CO LIMITED
心怡海購貿易有限公司 SAM JI HOI GAU TRADING LIMITED
邦維貿易有限公司 BONG WAI TRADING LIMITED
香港稻穗貿易有限公司 HONGKONG DAOSUI TRADING CO., LIMITED
進龍科技有限公司 DRAGON STEP TECHNOLOGY LIMITED
鉑威音響實業有限公司 Prime Audio Industry Co., Limited
Promivision Packaging Co., Limited
e2w studio LIMITED
香港出博國際教育有限公司 Hong Kong Tubor Global Education Limited
Heyface Trade Limited
LERAISE TRADE LIMITED
閃充數碼有限公司 Flash Top Digital Limited
恆興永豐國際有限公司 HENGXING YONGFENG INTERNATIONAL CO., LIMITED
元構空間設計有限公司 MetaSpatial Studio Limited
偉盛環球貿易有限公司 Wai Shing Global Trading Limited

Hong Kong Daily Policy, Industry, and Business News Roundup

Government Policy News

Hong Kong to Formulate First Five-Year Plan to Align with National Development

Financial Secretary Paul Chan announced that the HKSAR government has established a dedicated drafting group to compile Hong Kong's first-ever five-year plan (2026–2030). The initiative aims to align the city's socio-economic strategies with China's 15th Five-Year Plan. Speaking in a blog post, Chan emphasized that this framework will leverage Hong Kong's unique advantages to foster high-quality growth and better integration into the Guangdong-Hong Kong-Macao Greater Bay Area. The plan will focus on aligning regulatory mechanisms and facilitating the cross-border flow of innovative elements to ensure the city remains competitive.

Source : Xinhua News

Industry News

HSBC and Standard Chartered Poised to Receive Hong Kong's First Stablecoin Licenses

The Hong Kong Monetary Authority (HKMA) is reportedly set to grant its inaugural stablecoin issuer licenses to major note-issuing banks, including HSBC and Standard Chartered. This move is part of the government’s 2022 strategy to transform Hong Kong into a premier digital-asset hub. The HKMA is prioritizing institutions with strong capitalization to ensure financial stability and user safety. These licenses, which could be issued as early as March 2026, follow a rigorous review of 36 applications and a sandbox program involving key industry players like Animoca Brands and HKT.

Source : South China Morning Post

Ping An's Financial Large Language Model Ranks First in CNFinBench Evaluation

Ping An Insurance (Group) Company of China (HKEX: 2318) announced that its financial large language model, PingAnGPT-Qwen3-32B, achieved the top score on the CNFinBench leaderboard as of March 15, 2026. The benchmark, co-developed by the Shanghai AI Laboratory and financial authorities, evaluates models on expertise, reasoning, and compliance. The model outperformed several global and domestic competitors in financial factual reasoning and risk control. Currently deployed across the Group, the AI supports 97 real-world business scenarios, including claims processing and customer service, driving efficiency across its Hong Kong and mainland operations.

Source : PR Newswire

Company News

Akeso’s First Trispecific Antibody AK150 Receives IND Clearance for Clinical Trials

Akeso, Inc. (HKEX: 9926), a leading Hong Kong-listed biopharmaceutical company, announced that its proprietary trispecific antibody, AK150, has received Investigational New Drug (IND) clearance from the National Medical Products Administration (NMPA). AK150 is a global first-in-class molecule designed to target ILT2, ILT4, and CSF1R simultaneously, aiming to overcome immunotherapy resistance in patients with advanced solid tumors. This milestone highlights the company’s R&D capabilities in multispecific antibody therapeutics and its commitment to providing innovative, affordable treatments for complex diseases like lung and pancreatic cancer.

Source : PR Newswire

SINOPEC SEG Targets RMB 55 Billion in New Domestic Contracts for 2026

SINOPEC SEG (HKEX: 2386) announced its business targets for 2026 during an earnings conference, aiming for RMB 55 billion in new domestic contracts and US$ 5 billion in overseas orders. Despite a reported 27% drop in full-year net profit for the previous period, the company maintained a robust new order level of RMB 100 billion for the second consecutive year. Looking toward 2035, the group aims for main business revenue to exceed RMB 100 billion, with international business accounting for more than one-third of its total revenue, reinforcing its position in the global energy engineering sector.

Source : AASTOCKS

The above news content was generated by AI search, collection, and integration.